. . . . . "Pharmacogenomics-guided clopidogrel strategy represents a cost-effective treatment for patients undergoing PCI" . . . . . . . . . . . "Our data show that pharmacogenomics-guided clopidogrel treatment strategy may represent a cost-effective choice compared with non-pharmacogenomics-guided strategy for patients undergoing PCI." . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCJlM78d80R+gFMoQB1IG3f7AbqqGOCIv4HmZd1cx1KgEWMUUpPsojFNvx84fC/TltcJ8F8JafnbhDXW2HM2MhdK4yC04ROEV1vIgSzjDicHfiqXvMqdPuMyQp4mmCEY7mUoeEW10mWZqjk+S9TnmiAQbFGcpExP8aosr2aTR7CSQIDAQAB" . "QB48A6lfdmR/CEXbA4x4dn5mquRPNXjyvttOMRjoudp396TuV37KrUtG+bBpXP22QU1QOYe2ug47AREnfMIy8a29vCiVl8dG2yYZXCDzHIxiTiFf9FGleuFmNiqlQRx8b9EAsrXgvgjzVyMCMNnY6ep5BiVDdVhtoWVk1ubiE0E=" . . "2021-11-04T10:33:15.100+02:00"^^ . . . . . . . . . .